位置:首页 > 蛋白库 > PESC_HUMAN
PESC_HUMAN
ID   PESC_HUMAN              Reviewed;         588 AA.
AC   O00541; Q6IC29;
DT   20-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   03-AUG-2022, entry version 192.
DE   RecName: Full=Pescadillo homolog {ECO:0000255|HAMAP-Rule:MF_03028};
GN   Name=PES1 {ECO:0000255|HAMAP-Rule:MF_03028};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8985183; DOI=10.1101/gad.10.24.3141;
RA   Allende M.L., Amsterdam A., Becker T., Kawakami K., Gaiano N., Hopkins N.;
RT   "Insertional mutagenesis in zebrafish identifies two novel genes,
RT   pescadillo and dead eye, essential for embryonic development.";
RL   Genes Dev. 10:3141-3155(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   CHARACTERIZATION.
RX   PubMed=11071894; DOI=10.1074/jbc.m008536200;
RA   Kinoshita Y., Jarell A.D., Flaman J.-M., Foltz G., Schuster J.,
RA   Sopher B.L., Irvin D.K., Kanning K., Kornblum H.I., Nelson P.S., Hieter P.,
RA   Morrison R.S.;
RT   "Pescadillo, a novel cell cycle regulatory protein abnormally expressed in
RT   malignant cells.";
RL   J. Biol. Chem. 276:6656-6665(2001).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12022229; DOI=10.1017/s1355838202020022;
RA   Oeffinger M., Leung A., Lamond A., Tollervey D.;
RT   "Yeast Pescadillo is required for multiple activities during 60S ribosomal
RT   subunit synthesis.";
RL   RNA 8:626-636(2002).
RN   [7]
RP   ERRATUM OF PUBMED:12022229.
RA   Oeffinger M., Leung A., Lamond A., Tollervey D.;
RL   RNA 8:851-851(2002).
RN   [8]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12429849; DOI=10.1091/mbc.e02-05-0271;
RA   Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C.,
RA   Greco A., Hochstrasser D.F., Diaz J.-J.;
RT   "Functional proteomic analysis of human nucleolus.";
RL   Mol. Biol. Cell 13:4100-4109(2002).
RN   [9]
RP   INTERACTION WITH BOP1 AND WDR12, AND INDUCTION.
RX   PubMed=16043514; DOI=10.1083/jcb.200501141;
RA   Hoelzel M., Rohrmoser M., Schlee M., Grimm T., Harasim T., Malamoussi A.,
RA   Gruber-Eber A., Kremmer E., Hiddemann W., Bornkamm G.W., Eick D.;
RT   "Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required
RT   for ribosome biogenesis and cell proliferation.";
RL   J. Cell Biol. 170:367-378(2005).
RN   [10]
RP   FUNCTION, INTERACTION WITH BOP1 AND WDR12, AND SUBCELLULAR LOCATION.
RX   PubMed=16738141; DOI=10.1093/nar/gkl378;
RA   Grimm T., Hoelzel M., Rohrmoser M., Harasim T., Malamoussi A.,
RA   Gruber-Eber A., Kremmer E., Eick D.;
RT   "Dominant-negative Pes1 mutants inhibit ribosomal RNA processing and cell
RT   proliferation via incorporation into the PeBoW-complex.";
RL   Nucleic Acids Res. 34:3030-3043(2006).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH BOP1 AND WDR12.
RX   PubMed=17353269; DOI=10.1128/mcb.00172-07;
RA   Rohrmoser M., Hoelzel M., Grimm T., Malamoussi A., Harasim T., Orban M.,
RA   Pfisterer I., Gruber-Eber A., Kremmer E., Eick D.;
RT   "Interdependence of Pes1, Bop1, and WDR12 controls nucleolar localization
RT   and assembly of the PeBoW complex required for maturation of the 60S
RT   ribosomal subunit.";
RL   Mol. Cell. Biol. 27:3682-3694(2007).
RN   [12]
RP   FUNCTION, INTERACTION WITH BOP1 AND WDR12, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF PHE-327; ILE-347; ARG-380 AND TRP-397.
RX   PubMed=17189298; DOI=10.1093/nar/gkl1058;
RA   Hoelzel M., Grimm T., Rohrmoser M., Malamoussi A., Harasim T.,
RA   Gruber-Eber A., Kremmer E., Eick D.;
RT   "The BRCT domain of mammalian Pes1 is crucial for nucleolar localization
RT   and rRNA processing.";
RL   Nucleic Acids Res. 35:789-800(2007).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-98, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-517, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-517, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [19]
RP   STRUCTURE BY NMR OF 322-414.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the BRCT domain from human pescadillo homolog 1.";
RL   Submitted (OCT-2007) to the PDB data bank.
RN   [20]
RP   INTERACTION WITH DDX27.
RX   PubMed=25825154; DOI=10.1016/j.yexcr.2015.03.017;
RA   Kellner M., Rohrmoser M., Forne I., Voss K., Burger K., Muehl B.,
RA   Gruber-Eber A., Kremmer E., Imhof A., Eick D.;
RT   "DEAD-box helicase DDX27 regulates 3' end formation of ribosomal 47S RNA
RT   and stably associates with the PeBoW-complex.";
RL   Exp. Cell Res. 334:146-159(2015).
CC   -!- FUNCTION: Component of the PeBoW complex, which is required for
CC       maturation of 28S and 5.8S ribosomal RNAs and formation of the 60S
CC       ribosome. {ECO:0000255|HAMAP-Rule:MF_03028,
CC       ECO:0000269|PubMed:16738141, ECO:0000269|PubMed:17189298,
CC       ECO:0000269|PubMed:17353269}.
CC   -!- SUBUNIT: Component of the PeBoW complex, composed of BOP1, PES1 and
CC       WDR12 (PubMed:16043514, PubMed:16738141, PubMed:17189298,
CC       PubMed:17353269). The complex is held together by BOP1, which interacts
CC       with PES1 via its N-terminal domain and with WDR12 via a high-affinity
CC       interaction between the seven-bladed beta-propeller domains of the 2
CC       proteins. The PeBoW complex associates with the 66S pre-ribosome (By
CC       similarity). The PeBoW complex also associates with DDX27, PES1
CC       interacts directly with DDX27 (PubMed:25825154). Interacts with IRS1
CC       and UBTF. May interact with MAP1B (By similarity).
CC       {ECO:0000250|UniProtKB:Q9EQ61, ECO:0000255|HAMAP-Rule:MF_03028,
CC       ECO:0000269|PubMed:16043514, ECO:0000269|PubMed:16738141,
CC       ECO:0000269|PubMed:17189298, ECO:0000269|PubMed:17353269,
CC       ECO:0000269|PubMed:25825154}.
CC   -!- INTERACTION:
CC       O00541; P54253: ATXN1; NbExp=3; IntAct=EBI-1053271, EBI-930964;
CC       O00541; Q14137: BOP1; NbExp=4; IntAct=EBI-1053271, EBI-1050828;
CC       O00541; Q08050: FOXM1; NbExp=2; IntAct=EBI-1053271, EBI-866480;
CC       O00541; P42858: HTT; NbExp=3; IntAct=EBI-1053271, EBI-466029;
CC       O00541; Q9GZL7: WDR12; NbExp=4; IntAct=EBI-1053271, EBI-2490660;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus. Nucleus, nucleoplasm.
CC       Chromosome. Note=Appears to localize to the periphery of metaphase
CC       chromosomes during mitosis and to the prenucleolar bodies that form in
CC       mitotic cells prior to the actual nucleoli. {ECO:0000255|HAMAP-
CC       Rule:MF_03028}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O00541-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00541-2; Sequence=VSP_013023;
CC   -!- TISSUE SPECIFICITY: Significant levels are detected in a variety of
CC       cancer cell lines, including glioblastoma, breast carcinoma, colon
CC       carcinoma and cervical carcinoma cells. Levels are abnormally elevated
CC       in malignant tumors of astrocytic origin.
CC   -!- INDUCTION: By MYC. {ECO:0000269|PubMed:16043514}.
CC   -!- PTM: Sumoylated.
CC   -!- SIMILARITY: Belongs to the pescadillo family. {ECO:0000255|HAMAP-
CC       Rule:MF_03028}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U78310; AAB61140.1; -; mRNA.
DR   EMBL; CR456539; CAG30425.1; -; mRNA.
DR   EMBL; AC005006; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032489; AAH32489.1; -; mRNA.
DR   CCDS; CCDS13880.1; -. [O00541-1]
DR   CCDS; CCDS58802.1; -. [O00541-2]
DR   RefSeq; NP_001230154.1; NM_001243225.1. [O00541-2]
DR   RefSeq; NP_055118.1; NM_014303.3. [O00541-1]
DR   PDB; 2EP8; NMR; -; A=322-414.
DR   PDBsum; 2EP8; -.
DR   AlphaFoldDB; O00541; -.
DR   SMR; O00541; -.
DR   BioGRID; 117040; 210.
DR   CORUM; O00541; -.
DR   IntAct; O00541; 71.
DR   MINT; O00541; -.
DR   STRING; 9606.ENSP00000346725; -.
DR   iPTMnet; O00541; -.
DR   PhosphoSitePlus; O00541; -.
DR   SwissPalm; O00541; -.
DR   BioMuta; PES1; -.
DR   SWISS-2DPAGE; O00541; -.
DR   CPTAC; CPTAC-1171; -.
DR   CPTAC; CPTAC-1193; -.
DR   EPD; O00541; -.
DR   jPOST; O00541; -.
DR   MassIVE; O00541; -.
DR   MaxQB; O00541; -.
DR   PaxDb; O00541; -.
DR   PeptideAtlas; O00541; -.
DR   PRIDE; O00541; -.
DR   ProteomicsDB; 47963; -. [O00541-1]
DR   ProteomicsDB; 47964; -. [O00541-2]
DR   Antibodypedia; 10811; 274 antibodies from 33 providers.
DR   DNASU; 23481; -.
DR   Ensembl; ENST00000335214.8; ENSP00000334612.6; ENSG00000100029.18. [O00541-2]
DR   Ensembl; ENST00000354694.12; ENSP00000346725.6; ENSG00000100029.18. [O00541-1]
DR   GeneID; 23481; -.
DR   KEGG; hsa:23481; -.
DR   MANE-Select; ENST00000354694.12; ENSP00000346725.6; NM_014303.4; NP_055118.1.
DR   UCSC; uc003aij.2; human. [O00541-1]
DR   CTD; 23481; -.
DR   DisGeNET; 23481; -.
DR   GeneCards; PES1; -.
DR   HGNC; HGNC:8848; PES1.
DR   HPA; ENSG00000100029; Low tissue specificity.
DR   MIM; 605819; gene.
DR   neXtProt; NX_O00541; -.
DR   OpenTargets; ENSG00000100029; -.
DR   PharmGKB; PA33190; -.
DR   VEuPathDB; HostDB:ENSG00000100029; -.
DR   eggNOG; KOG2481; Eukaryota.
DR   GeneTree; ENSGT00390000002626; -.
DR   HOGENOM; CLU_019619_0_0_1; -.
DR   InParanoid; O00541; -.
DR   OMA; TWIVPHY; -.
DR   PhylomeDB; O00541; -.
DR   TreeFam; TF300671; -.
DR   PathwayCommons; O00541; -.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   SignaLink; O00541; -.
DR   SIGNOR; O00541; -.
DR   BioGRID-ORCS; 23481; 770 hits in 1064 CRISPR screens.
DR   ChiTaRS; PES1; human.
DR   EvolutionaryTrace; O00541; -.
DR   GeneWiki; PES1; -.
DR   GenomeRNAi; 23481; -.
DR   Pharos; O00541; Tbio.
DR   PRO; PR:O00541; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; O00541; protein.
DR   Bgee; ENSG00000100029; Expressed in sural nerve and 174 other tissues.
DR   ExpressionAtlas; O00541; baseline and differential.
DR   Genevisible; O00541; HS.
DR   GO; GO:0005694; C:chromosome; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0070545; C:PeBoW complex; IDA:UniProtKB.
DR   GO; GO:0030687; C:preribosome, large subunit precursor; IDA:UniProtKB.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; IMP:MGI.
DR   GO; GO:0000466; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IMP:UniProtKB.
DR   GO; GO:0000463; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IMP:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; IMP:UniProtKB.
DR   GO; GO:0042273; P:ribosomal large subunit biogenesis; IC:UniProtKB.
DR   GO; GO:0006364; P:rRNA processing; IMP:MGI.
DR   Gene3D; 3.40.50.10190; -; 1.
DR   HAMAP; MF_03028; Pescadillo; 1.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR036420; BRCT_dom_sf.
DR   InterPro; IPR010613; PES.
DR   PANTHER; PTHR12221; PTHR12221; 1.
DR   Pfam; PF16589; BRCT_2; 1.
DR   Pfam; PF06732; Pescadillo_N; 1.
DR   SMART; SM00292; BRCT; 1.
DR   SUPFAM; SSF52113; SSF52113; 1.
DR   PROSITE; PS50172; BRCT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromosome;
KW   Isopeptide bond; Nucleus; Reference proteome; Ribosome biogenesis;
KW   rRNA processing; Ubl conjugation.
FT   CHAIN           1..588
FT                   /note="Pescadillo homolog"
FT                   /id="PRO_0000186188"
FT   DOMAIN          322..415
FT                   /note="BRCT"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03028"
FT   REGION          1..257
FT                   /note="Sufficient for nucleolar localization"
FT   REGION          1..54
FT                   /note="Required for 28S ribosomal RNA processing"
FT   REGION          294..314
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          306..415
FT                   /note="Sufficient for interaction with MAP1B"
FT                   /evidence="ECO:0000250"
FT   REGION          448..515
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          539..588
FT                   /note="Required for 28S ribosomal RNA processing"
FT   REGION          565..588
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        454..488
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        489..515
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         98
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   CROSSLNK        517
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        517
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211,
FT                   ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         306..310
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15461802"
FT                   /id="VSP_013023"
FT   VARIANT         264
FT                   /note="T -> S (in dbSNP:rs42942)"
FT                   /id="VAR_034375"
FT   VARIANT         370
FT                   /note="D -> H (in dbSNP:rs11541876)"
FT                   /id="VAR_053570"
FT   VARIANT         411
FT                   /note="A -> T (in dbSNP:rs34123894)"
FT                   /id="VAR_053571"
FT   MUTAGEN         327
FT                   /note="F->R: Reduces incorporation into the PeBoW complex
FT                   and nucleolar localization and impairs maturation of 28S
FT                   ribosomal RNA."
FT                   /evidence="ECO:0000269|PubMed:17189298"
FT   MUTAGEN         347
FT                   /note="I->R: Reduces incorporation into the PeBoW complex
FT                   and nucleolar localization and impairs maturation of 28S
FT                   ribosomal RNA."
FT                   /evidence="ECO:0000269|PubMed:17189298"
FT   MUTAGEN         380
FT                   /note="R->W: Slightly impairs nucleolar localization."
FT                   /evidence="ECO:0000269|PubMed:17189298"
FT   MUTAGEN         397
FT                   /note="W->R: Reduces incorporation into the PeBoW complex
FT                   and nucleolar localization and impairs maturation of 28S
FT                   ribosomal RNA."
FT                   /evidence="ECO:0000269|PubMed:17189298"
FT   STRAND          331..333
FT                   /evidence="ECO:0007829|PDB:2EP8"
FT   STRAND          336..338
FT                   /evidence="ECO:0007829|PDB:2EP8"
FT   HELIX           340..349
FT                   /evidence="ECO:0007829|PDB:2EP8"
FT   STRAND          353..355
FT                   /evidence="ECO:0007829|PDB:2EP8"
FT   TURN            358..360
FT                   /evidence="ECO:0007829|PDB:2EP8"
FT   STRAND          375..377
FT                   /evidence="ECO:0007829|PDB:2EP8"
FT   TURN            381..383
FT                   /evidence="ECO:0007829|PDB:2EP8"
FT   STRAND          390..393
FT                   /evidence="ECO:0007829|PDB:2EP8"
FT   HELIX           396..404
FT                   /evidence="ECO:0007829|PDB:2EP8"
FT   TURN            410..412
FT                   /evidence="ECO:0007829|PDB:2EP8"
SQ   SEQUENCE   588 AA;  68003 MW;  CB6201D6E34D82B1 CRC64;
     MGGLEKKKYE RGSATNYITR NKARKKLQLS LADFRRLCIL KGIYPHEPKH KKKVNKGSTA
     ARTFYLIKDI RFLLHEPIVN KFREYKVFVR KLRKAYGKSE WNTVERLKDN KPNYKLDHII
     KERYPTFIDA LRDLDDALSM CFLFSTFPRT GKCHVQTIQL CRRLTVEFMH YIIAARALRK
     VFLSIKGIYY QAEVLGQPIV WITPYAFSHD HPTDVDYRVM ATFTEFYTTL LGFVNFRLYQ
     LLNLHYPPKL EGQAQAEAKA GEGTYALDSE SCMEKLAALS ASLARVVVPA TEEEAEVDEF
     PTDGEMSAQE EDRRKELEAQ EKHKKLFEGL KFFLNREVPR EALAFIIRSF GGEVSWDKSL
     CIGATYDVTD SRITHQIVDR PGQQTSVIGR CYVQPQWVFD SVNARLLLPV AEYFSGVQLP
     PHLSPFVTEK EGDYVPPEKL KLLALQRGED PGNLNESEEE EEEDDNNEGD GDEEGENEEE
     EEDAEAGSEK EEEARLAALE EQRMEGKKPR VMAGTLKLED KQRLAQEEES EAKRLAIMMM
     KKREKYLYQK IMFGKRRKIR EANKLAEKRK AHDEAVRSEK KAKKARPE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025